This metabolite features a PDE selectivity profile just like sildenafil and an in vitro potency for PDE5 somewhere around 50% on the parent drug. Plasma concentrations of the metabolite are close to forty% of These seen for sildenafil, so that the metabolite accounts for around twenty% of sildenafil’s pharmacologic consequences.Continue to keep s